[Editorial] Are adolescent and young adult cancer patients affected by ‘chemobrain’?: A call for evidence

Chan, Alexandre, Ng, Terence, Chan, Raymond Javan, Poon, Eileen, & Mohamad, Farid (2016) [Editorial] Are adolescent and young adult cancer patients affected by ‘chemobrain’?: A call for evidence. Expert Review of Quality of Life in Cancer Care, 1(3), pp. 187-188.

[img] Accepted Version (PDF 39kB)
Administrators only until November 2017 | Request a copy from author

View at publisher

Abstract

An adolescent and young adult (AYA) cancer patient is defined as an individual of 15 to 39 years of age at the time of initial cancer diagnosis.1,2 The number of AYA cancer survivors has dramatically increased over the past decades due to availability of novel therapeutics, with the 5-year overall survival rate among adolescents aged 15 to 19 years old exceeds 80% for most cancers.3 AYA cancer survivors, however, often experience a myriad of treatment-related chronic and late toxicities that can lead to functional impairment at great economic, emotional and social cost.4 As the cure rates of AYA cancers continue to improve and survivors live longer, post-treatment health issues in these survivors are becoming increasingly relevant, and more in-depth research is needed in this group of patients...

Impact and interest:

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 95396
Item Type: Journal Article
Refereed: Yes
Keywords: Cognitive Impairment, Adolescent and Young Adult, Survivorship, Cancer, Quality of life, Chemobrain
DOI: 10.1080/23809000.2016.1181977
ISSN: 2380-9000
Subjects: Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > NURSING (111000)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2016 Taylor & Francis
Deposited On: 05 May 2016 22:48
Last Modified: 17 Jun 2016 03:13

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page